9th Symposium

Round Table
Antiretroviral therapy cardiovascular disease and neurocognitive impairment.
Round Table

Speakers

Ignacio Pérez-Valero, M.D., Ph.D.

Hospital Universitario Reina Sofia. Córdoba, Spain

Ignacio Pérez-Valero MD PhD is a 43 years-old Consultant Physician of Internal Medicine at the Reina Sofía University Hospital. Córdoba, Spain.

Read More

Efficacy of current antiretroviral therapy on CNS

Esteban Martínez Chamorro, M.D.

Infectious Diseases Unit. Hospital U. Clinic. Barcelona, Spain

Dr. Esteban Martínez is a senior consultant in the Infectious Diseases Unit of the Hospital Clínic de Barcelona. He is also coordinator of the Treatment Program for Facial Lipoatrophy in people with HIV of the Health Department of the Generalitat de Catalunya and Associate Professor of Medicine. His main fields of interest are the optimization of antiretroviral therapy and comorbidities in adults with HIV infection. He is a member of the steering committee of the European neat-id network for the treatment of HIV, hepatitis and global infectious diseases and research director of the Reprieve clinical trial, the largest conducted in the prevention of vascular events in HIV.

Dr. Esteban Martínez has been president of the Spanish HIV Study Group (GeSida) between 2019 and 2021, and is the president-elect of the European AIDS Clinical Society (EACS) for the period 2020-2024. He is a founding member and Coordinator of the International Symposium on Psychiatry and HIV since 2008.

Read More

Characteristics of the “asymptomatic” HIV-infected patient with potential underlying CNS toxicity

Andrea de Luca, M.D.

Infectious Diseases, Department of Medical Biotechnologies. University of Siena. Italy

 

Read More

Neurocognitive impairment and cardiovascular disease